Psychopharmacology & Novel Therapeutic Agents

Psychopharmacology in addiction focuses on the development and application of novel therapeutic agents to target neurotransmitter dysregulation, craving, withdrawal, and relapse. New compounds aim to modulate dopaminergic, glutamatergic, and GABAergic pathways implicated in addictive behaviors. Emerging therapies include long-acting formulations, combination medications, and receptor-specific modulators designed to enhance efficacy while minimizing side effects. Personalized psychopharmacology integrates genetic testing and metabolic profiling to tailor treatments to individual patient needs. Clinical trials increasingly evaluate novel agents alongside behavioral therapies to maximize recovery outcomes. Advanced drug delivery systems, such as implantable devices and nanocarriers, offer sustained medication release and improved adherence. Integration with digital monitoring tools ensures real-time feedback and safety oversight. Psychopharmacology research is expanding into non-substance behavioral addictions, exploring medications that target impulse control, compulsive behaviors, and neuroplasticity. By advancing evidence-based pharmacological strategies, clinicians can complement psychological interventions, improve treatment retention, and reduce relapse rates, offering a more comprehensive approach to addiction management.

    Related Conference of Psychopharmacology & Novel Therapeutic Agents

    February 16-17, 2026

    6th Annual Congress on Mental Health

    Paris, France
    February 16-16, 2026

    43rd Global Psychiatry and Mental Health Conference

    Paris, France
    March 09-10, 2026

    7th Annual Congress on Psychiatry

    Singapore City, Singapore
    March 23-24, 2026

    4th World Congress on Psychiatry

    Tokyo, Japan
    April 13-14, 2026

    8th International Congress on Mental Health

    Tokyo, Japan
    April 20-21, 2026

    33rd World Psychiatrists and Psychologists Meet

    Rome, Italy
    May 27-28, 2026

    8th European Autism Congress

    Paris, France
    June 01-02, 2026

    11th International Conference on Addiction Therapy

    Zurich, Switzerland

    Psychopharmacology & Novel Therapeutic Agents Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in